| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/08/1999 | WO1999033522A2 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | WO1999033492A1 Method for tissue perfusion |
| 07/08/1999 | WO1999033491A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033490A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033489A1 Sustained release medicinal compositions |
| 07/08/1999 | WO1999033486A1 Composition and method for dermal and transdermal administration of a cytokine |
| 07/08/1999 | WO1999033483A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 07/08/1999 | WO1999033471A1 A gel-form pharmaceutical preparation |
| 07/08/1999 | WO1999033467A1 Method and composition of an oral preparation of itraconazole |
| 07/08/1999 | WO1999033466A1 Pharmaceutical composition for oral administration |
| 07/08/1999 | WO1999033464A1 Water-base liquid preparation |
| 07/08/1999 | WO1999033459A1 Methods of inactivating bacteria including bacterial spores |
| 07/08/1999 | WO1999033458A1 Medicinal composition for percutaneous administration |
| 07/08/1999 | WO1999033457A1 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 07/08/1999 | WO1999033456A1 Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer |
| 07/08/1999 | WO1999033451A2 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
| 07/08/1999 | WO1999033448A1 Tablet for instant and prolonged release of one or more active substances |
| 07/08/1999 | WO1999033445A1 Tablet composition |
| 07/08/1999 | WO1999033441A1 Composition for cosmetic, dietetic or pharmaceutical use |
| 07/08/1999 | WO1999033415A1 Osteopontin-based compositions for enhancing bone repair |
| 07/08/1999 | WO1999024073B1 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 07/08/1999 | WO1999021586A3 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions |
| 07/08/1999 | WO1999020305A8 Veterinary vaccines |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999009955A3 Lipid-containing compositions and uses thereof |
| 07/08/1999 | WO1999009057A3 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 07/08/1999 | CA2317698A1 Composition and method for dermal and transdermal administration of a cytokine |
| 07/08/1999 | CA2317120A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | CA2317021A1 Tablet composition |
| 07/08/1999 | CA2316986A1 Aqueous liquid preparation |
| 07/08/1999 | CA2316275A1 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | CA2315853A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof |
| 07/08/1999 | CA2315092A1 Method for tissue perfusion |
| 07/07/1999 | EP0927214A1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
| 07/07/1999 | EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/07/1999 | EP0927174A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds |
| 07/07/1999 | EP0927159A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications |
| 07/07/1999 | EP0927053A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927037A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | EP0927019A1 Compositions for cosmetic applications |
| 07/07/1999 | EP0926955A1 Conjugates useful in the treatment of prostate cancer |
| 07/07/1999 | EP0689444B1 Tylosin containing sustained release veterinary compositions |
| 07/07/1999 | EP0585412B1 Increasing blood-brain barrier permeability with permeabilizer peptides |
| 07/07/1999 | EP0580803B1 Antimicrobial compositions useful for medical applications |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222084A Insulin preparations containing carbohydrates |
| 07/07/1999 | CN1222083A Insulin Preparations containing NaCl |
| 07/07/1999 | CN1222082A Compsns. comprising antifungal agent and acetate buffer |
| 07/07/1999 | CN1222053A Low PH acidic compns. |
| 07/07/1999 | CN1221607A Liposoluble medicinal liposome prodn. tech. and elemene liposome injecta |
| 07/07/1999 | CN1043957C Method for prepn. of multi-unit dosage of oral medicine |
| 07/06/1999 | US5919922 Fluorescent dyes free of aggregation and serum binding |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919908 Protein formulation comprising coagulation factor VIII or factor IX in an aqueous solution |
| 07/06/1999 | US5919835 Two or more polymers from the group consisting of polyesters and polyanhydrides, forming a melt, determining whether the polymers are miscible by determining if phase separation occurs when the polymer blend is dissolved in a solvent in |
| 07/06/1999 | US5919830 Non-ionic solid triblock eo/po/eo copolymer of mw=8500-25,000 and polyoxyalkylene glycol |
| 07/06/1999 | US5919766 Storage stability by incorporating nonionic surfactant, sodium or potassium chloride, histidine |
| 07/06/1999 | US5919762 Conjugates of hirudin and lipophilic compounds |
| 07/06/1999 | US5919757 Granulocyte colony stimulating factor mixture containingbuffer and surfactant |
| 07/06/1999 | US5919753 Crosslinking a protein or carbohydrate substrate to form crosslinked substrate in which crosslinking groups are biodegradable; i.e. crosslinking galactose with methylene diacrylate; ultrasound contrast agent |
| 07/06/1999 | US5919489 Process for aqueous granulation of clarithromycin |
| 07/06/1999 | US5919486 Powder preparation and a process for preparing the same |
| 07/06/1999 | US5919485 Oral 2-methyl-thieno-benzodiazepine formulation |
| 07/06/1999 | US5919481 Translucence, semi-solid |
| 07/06/1999 | US5919478 Incorporating poly-N-vinyl amide in a transdermal system |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/06/1999 | US5919443 Stable lyophilized pharmaceutical preparations of G-CSF |
| 07/06/1999 | US5919442 Hyper comb-branched polymer conjugates |
| 07/06/1999 | US5919439 Useful for delivering and/or transdermally transporting active ingredients; hair styling |
| 07/06/1999 | US5919398 Oil-water mixed composition |
| 07/06/1999 | CA2130762C Treatment of disease and conditions associated with macrophage infiltration |
| 07/06/1999 | CA2011063C Nicardipine pharmaceutical composition for parenteral administration |
| 07/01/1999 | WO1999032540A1 Hyperbranched polymers or dendrimers having a particular group, preparation method and compositions containing same |
| 07/01/1999 | WO1999032536A1 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 07/01/1999 | WO1999032513A1 Protein binding polypeptides |
| 07/01/1999 | WO1999032503A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 07/01/1999 | WO1999032216A1 Use of cyclic carbonates |
| 07/01/1999 | WO1999032167A1 Glass fiber chemical delivery system |
| 07/01/1999 | WO1999032158A2 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/01/1999 | WO1999032153A1 Monoglyceride and ethyl palmitate permeation enhancer compositions |
| 07/01/1999 | WO1999032152A2 Methods for delivering pharmaceutical agents to mucosal surfaces |
| 07/01/1999 | WO1999032151A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | WO1999032143A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium |
| 07/01/1999 | WO1999032140A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 07/01/1999 | WO1999032135A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | WO1999032134A1 Substantially pure histidine-linked protein polymer conjugates |
| 07/01/1999 | WO1999032130A1 Medicinal plant dry extracts |
| 07/01/1999 | WO1999032128A1 Orally administrable solid ribavirin dosage forms and process for making them |
| 07/01/1999 | WO1999032118A1 Molecular dispersion composition with enhanced bioavailability |
| 07/01/1999 | WO1999032116A1 Insoluble compositions for controlling blood glucose |
| 07/01/1999 | WO1999032113A1 Application of enzyme prodrugs as anti-infective agents |
| 07/01/1999 | WO1999032107A1 Compositions comprising cannabinoids |
| 07/01/1999 | WO1999032096A1 Novel formulations for the transdermal administration of asimadoline |
| 07/01/1999 | WO1999032095A1 Rate controlling membranes for controlled drug delivery devices |